Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $11.09 | Prev. Close $10.62 | Circuit Range N/A |
Day Range $10.70 - $11.23 | Year Range $0.91 - $16.34 | Volume 1,480 |
Average Traded $10.95 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
25-Feb-26 | $12.01 | $10.57 | -8.44% |
24-Feb-26 | $9.85 | $11.55 | +22.09% |
23-Feb-26 | $9.00 | $9.46 | +12.09% |
20-Feb-26 | $8.51 | $8.44 | +0.18% |
19-Feb-26 | $8.13 | $8.43 | +2.74% |
18-Feb-26 | $8.22 | $8.20 | +0.86% |
17-Feb-26 | $8.01 | $8.13 | +1.26% |